Image Image Image Image Image Image Image Image Image Image
Accessibilité
Haut de page

Up

Foto45_2

· 26/03/2013

MPL4 DRUSEN. A phase I study to establish the safety and efficacy of retinal pigment epithelium micropulse laser in subjects with high-risk drusen secondary to age-related macular degeneration 

Foto43_1

· 26/03/2013

Translational research in regenerative stem cell therapies for retinal degenerative diseases: from the swine animal model of retinal atrophy to clinical trials in human patients with age-related macular degeneration, retinitis pigmentosa and Stargardt’s disease

Foto42_3

· 26/03/2013

GAP. A phase I escalating dose of subretinal sodium iodate: a toxi-induced animal model of geography atrophy of RPE and phtotoreceptors

_MG_7643

· 26/03/2013

Pilot phase II clinical trial to evalute safety of human fetal retinal transplant in the treatment of geographic atrophy secondary to age-related macular degeneration and retinitis pigmentosa

Foto52_2

· 26/03/2013

An open-label investigator research trial to study the safety and efficacy of a combination of a pro re nata regimen with fixed interval regimen intravitreal injections of ranibizumab in the treatment of choroidal neovascularization in subjects with neovascular age-related macular degeneration

Foto55_1

· 26/03/2013

An open-label investigator research grant trial to establish the safety of intravitreous injections of E10030 (anti-PDGF pegylated aptamer) given in combination with Lucentis® in subjects with neovascular age-related macular degeneration

Foto54_1

· 26/03/2013

A phase II, randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous injections of E10030 (anti-PDGF pegylated aptamer) given in combination with Lucentis® in subjects with neovascular age-related macular degeneration 

Foto53_4

· 26/03/2013

A phase I study to establish the safety and tolerability of ARC1905 (Anti-C5 Aptamer) in subjects with dry age-related macular degeneration

Last modified: 17 July, 2019 - 14:57